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Progressive age-dependence and frequency difference in the 
effect of gap junctions on active cochlear amplification and 
hearing
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2Department of Otolaryngology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, 
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Abstract
Mutations of Connexin 26 (Cx26, GJB2), which is a predominant isoform in the cochlea, can 
induce high incidence of nonsyndromic hearing loss. We previously found that targeted-deletion of 
Cx26 in supporting Deiters cells and outer pillar cells in the cochlea can influence outer hair cell 
(OHC) electromotility and reduce active cochlear amplification leading to hearing loss, even 
though there are no gap junction connexin expressions in the auditory sensory hair cells. Here, we 
further report that hearing loss and the reduction of active amplification in the Cx26 conditional 
knockout (cKO) mice are progressive and different at high and low frequency regions, first 
occurring in the high frequency region and then progressively extending to the middle and low 
frequency regions with mouse age increased. The speed of hearing loss extending was fast in the 
basal high frequency region and slow in the apical low frequency region, showing a logarithmic 
function with mouse age. Before postnatal day 25, there were no significant hearing loss and the 
reduction of active cochlear amplification in the low frequency region. Hearing loss and the 
reduction of active cochlear amplification also had frequency difference, severe and large in the 
high frequency regions. These new data indicate that the effect of gap junction on active cochlear 
amplification is progressive, but, consistent with our previous report, exists in both high and low 
frequency regions in adulthood. These new data also suggest that cochlear gap junctions may have 
an important role in age-related hearing loss.
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In the mammalian cochlea, outer hair cells (OHCs) can be motile under acoustic/electronic 
stimulation [1]. This OHC electromotility acts as an active cochlear amplifier to burst the 
basilar membrane vibration increasing hearing sensitivity and frequency selectivity [1,2]. 
This active cochlear amplification is required for normal hearing in mammalians. Knockout 
of prestin, which is the motor protein of OHC electromotility, induces hearing loss [3,4].
In vivo, OHCs are surrounded by supporting cells. The cochlear supporting cells are well-
coupled by gap junctions [5,6]. Connexin26 (Cx26) and Cx30 are predominant connexin gap 
junction isoforms in the inner ear [6–10]. Cx26 (GJB2) mutations can induce hearing loss 
and account for more than 50% cases of nonsyndromic hearing loss [6, 11–13]. Connexin 
expression and gap junctions in the cochlea only exist in non-sensory supporting cells but 
not in sensory hair cells including OHCs [7,9,14–16]. However, our previous studies 
demonstrated that gap junctional coupling between cochlear supporting cells can influence 
OHC electromotility and active cochlear amplification [16], indicating that connexin gap 
junctions in the cochlea play more broad and important functions in hearing. Our recent 
studies further demonstrated that knockout of Cx26 expression in the cochlear supporting 
cells can affect OHC electromotility leading to hearing loss [17,18]. Target-deletion of C26 
in the cochlear supporting Deiters cells (DCs) and outer pillar cells (OPCs), which constrain 
OHCs standing on the basilar membrane, can reduce OHC electromotility and active 
cochlear amplification and cause hearing loss [17]. In this study, we further found that the 
hearing loss and reduction of active cochlear amplification are progressive, extending from 
high-frequency region to low-frequency region with mouse age, and also have difference in 
high and low frequency regions. The new data demonstrate that gap junction can regulate 
active cochlear amplification in apical low-frequency region as well as the basal high-
frequency region but the regulation in the high-frequency region are more susceptible and 
vulnerable to be impaired. Our new findings provide a light on why hearing function in 
high-frequency range is vulnerable to be compromised with aging and noise stress.
Materials and Methods
Cx26 conditional KO mouse generation and genotyping
As described in our previous report [17], Prox1-CreERT2(+/+);Cx26LoxP(+/−) mice were 
generated by crossing of Cx26loxP/loxP transgenic mice (EMMA, EM00245) [19,20] with 
Prox1-CreERT2 mouse line (Stock No. 022075, Jackson Laboratory, USA) and used for 
breeding. Mouse genotyping was identified by PCR amplification of tail genomic DNA. 
Tamoxifen (T5648, Sigma-Aldrich, St. Louis, MO) was administrated to all litters at 
postnatal day 0 (P0) by intraperitoneal injection (0.5 mg/10g × 3 days) [17]. Prox1-
CreERT2(+/+);Cx26LoxP(+/+) mice were used as Cx26-Preox1 conditional knockout (cKO) 
mice and littermates of Prox1-CreERT2(+/+);Cx26LoxP(−/−) were used as wild-type (WT) 
control. All experimental procedures were conducted in accordance with the National 
Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 
8023, revised 1978) and the policies of University of Kentucky Animal Care & Use 
Committee.
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Auditory brainstem response and distortion product otoacoustic emission measurements
As described in our previous reports [17,18,20], auditory brainstem response (ABR) and 
distortion product otoacoustic emission (DPOAE) were recorded by use of a Tucker-Davis 
ABR & DPOAE workstation with ES-1 high frequency speaker (Tucker-Davis Tech. 
Alachua, FL). ABR was recorded by stimulation with clicks in alternative polarity and tone 
bursts (4–40 kHz) in a 5 dB step and was averaged by 500 times. The ABR threshold was 
determined by the lowest level at which an ABR can be recognized. For DPOAE recording, 
the test frequencies were presented by a geometric mean of f1 and f2 [f0 = (f1 × f2)1/2] from 
f0=4 to 20 kHz. The distortion product was recorded from the L1/L2 level of 60/55 to 25/20 
dB SPL with average of 150 times. A cubic distortion component of 2f1–f2 was measured.
Immunofluorescent staining and confocal microscopy
The cochlear tissue preparation and immunofluorescent staining were performed as 
previously reported [9, 10]. Monoclonal mouse anti-Cx26 (Cat# 33-5800), polyclonal rabbit 
anti-Cx30 (Cat#71-2200, Invitrogen Corp, Carlsbad, CA), and monoclonal mouse anti-
prestin (a kind gift from Dr. Jing Zheng at Northwestern University) were used and 
visualized by secondary Alexa Fluor® 488 or 568 conjugated antibodies (Molecular 
Probes). The staining was observed under fluorescence or confocal laser-scanning 
microscopes.
Statistical analysis
Data were plotted by SigmaPlot and statistically analyzed by SPSS (SPSS Inc.; Chicago, 
IL). Error bars represent SEM.
Results
Deletion of Cx26 in the cochlea in Cx26-Prox1 cKO mice
Fig. 1 shows immunofluorescent staining for Cx26 in the cochlea of Cx26-Prox1 cKO mice. 
Cx26 labeling in DC and OPC area in Cx26 cKO mice was absent (Fig. 1C–F). However, 
Cx30 expression still remained in this region (Fig. 1E&F). Also, Cx26 deletion had no 
apparent difference along the cochlear sensory epithelium in whole-mounting preparation 
(Fig. 1D), indicating that there was no apparent difference in Cx26 deletion in low and high 
frequency region as demonstrated in our previous report [17].
Progress and frequency difference of hearing loss in Cx26-Prox1 cKO mice
Cx26-Prox1 cKO mice had hearing loss (Fig. 2) as demonstrated in our previous study [17]. 
However, hearing loss appears progressively age-dependent and difference in low and high 
frequencies (Figs. 2&3). At postnatal day 15 (P15), ABR thresholds in both Cx26 cKO and 
WT mice had no significant difference (Fig. 2A). At P25 (Fig. 2B), there was still no 
difference in the ABR thresholds between Cx26 cKO and WT mice at middle and low 
frequencies. However, at 40 kHz high-frequency, ABR threshold in Cx26 cKO mice was 
significantly increased to 64.5±2.41 dB SPL, increasing about 21.7 dB SPL in comparison 
with 42.8±3.32 dB SPL in WT mice (Fig. 2B). Then, hearing loss progressively extended to 
middle and low frequency regions. At P35, ABR threshold at 24 kHz in Cx26 cKO mice was 
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significantly increased to 46.3±3.37 dB SPL (Fig. 2C) and at P45 the ABR threshold at 16 
kHz was significantly increased to 43.5±1.30 dB SPL (Fig. 2D). Finally, at P60, the ABR 
thresholds in Cx26 cKO mice were significantly increased for 8 kHz tone and click 
stimulation (Fig. 2E).
The speed of hearing loss extending from high frequency to low frequency in Cx26 cKO 
mice was fast in the high frequency region and slow in the low frequency region (Fig. 3B). 
The first time of hearing loss occurrence at frequency could be described by a common 
logarithmic function: log y (kHz) = 2.087−0.0198 * × (day) (Fig. 3B). The estimated time of 
hearing loss occurring at 60 kHz, which is at the highest frequency region in mouse hearing, 
is expected at ~P15.5, just after mouse hearing starting (P13–14) [20].
The increase of ABR threshold in Cx26 cKO mice is also different in low and high-
frequency regions (Figs. 2 and 3A). In the frequency region >24 kHz, ABR threshold was 
increased largely (Fig. 3A). At P60, ABR threshold increase in >24 kHz frequency regions 
was about 40 dB SPL, whereas the increase of ABR threshold at <16 kHz frequency region 
was only about 10 dB SPL (Fig. 3A).
The degree of hearing loss was also progressively increased with mouse age (Fig. 3C). For 
example, at 24 kHz, ABR threshold was significantly increased by ~10, 20, and 40 dB SPL 
at P35, P45, and P60, respectively. At 16 kHz, the increase in ABR threshold at P60 in Cx26 
cKO mice was 10.1±3.77 dB SPL (Fig. 3C). However, the increase of ABR threshold at P80 
was increased to 34.4±7.15 dB SPL (Fig. 3C). The maximum of ABR threshold increase in 
Cx26 cKO mice was about 40 dB SPL (Figs. 2&3).
Progressive reduction of active cochlear amplification in Cx26 cKO mice
As mentioned above, mammalian hearing relies upon active cochlear amplification. 
Deficiency of active cochlear amplification can induce hearing loss. Fig. 4 shows that active 
cochlear amplification as measured by DPOAE in Cx26 cKO mice was reduced. The 
reduction was also progressive. Before P25, there was no any DPOAE reduction detectable 
in the tested frequencies in Cx26 cKO mice (Fig. 4A–D). At P30, DPOAEs at 16 and 20 
kHz in Cx26 cKO mice were significantly reduced (Fig. 4C&D). The reduction was also 
progressively extended to the low-frequency (Fig. 4E). At P80, the significant reduction of 
DPOAE in Cx26 cKO mice was detected at 8 kHz (Fig. 4B&E). However, the reduction was 
small (−5.70±2.27 dB) in comparison with those at 16 and 20 kHz, at which the reduction 
was −20.4±6.09 dB and −27.1±4.19 dB, respectively (Fig. 4E).
Discussion
We previously reported that gap junctions between DCs can mediate OHC electromotility 
[16]. Targeted-deletion of Cx26 in DCs and OPCs could shift OHC electromotility and 
reduced DPOAE leading to hearing loss [17]. In this study, we further found that hearing 
loss and the reduction of active cochlear amplification in Cx26-Prox1 cKO mice are age-
dependent, progressively extending from high-frequency region to low-frequency region 
with mouse age (Figs. 2–4). Hearing loss and the reduction at high and low frequency 
regions were also different, severe at high frequencies (Figs. 2–4). These new findings 
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suggest that Cx26 deficiency can reduce active cochlear amplification inducing hearing loss 
in both high and low frequencies.
In this study, we found that the hearing loss and the reduction of DPOAE in Cx26-Prox1 
cKO mice were more apparent at middle and high frequency regions in comparison with 
those in the low frequency region (Figs. 2–4). This corresponds well with the gradient 
expression of Cx26 at the cochlear sensory epithelium. We previously found that Cx26 
expression at the high frequency basal turn is less than that at the low-frequency apical turn, 
and that Cx26 function at the high frequency region is susceptible to be impaired [9]. 
DPOAE reduction and hearing loss appeared severe at high frequencies (Figs. 2–4). This 
may also imply that gap junctions between supporting cells at high frequency region are 
more important and critical than those at low frequency region for active cochlear 
amplification.
Hearing loss and the reduction of active cochlear amplification in Cx26-Prox1 cKO mice 
first occurred at the high-frequency region, then progressively extending to middle and low 
frequency regions with age (Figs. 2–4). At <P25, there was no hearing loss in middle and 
low frequency ranges in Cx26-Prox1 cKO mice, except 40 kHz (Figs. 2–3). DPOAE also 
had no significant reduction in the tested frequencies (4–20 kHz) (Fig. 4). However, at P45, 
Cx26-Prox1 cKO mice had significant increase in ABR threshold and decrease in DPOAE at 
16 kHz middle frequency region (Figs. 2–4). We further found that the speed of hearing loss 
extending from high-frequency to low-frequency could be described as a logarithmic 
function, showing a linear function in the plot with logarithmic frequency scale (Fig. 3B). 
This corresponds with logarithmic changes of frequency in the cochlear sensory epithelium.
The reduction of DPOAE was large at the high stimulus levels and increased as the sound 
intensity was increased (Fig. 4F). The reduction also first occurred at high intensity region 
(Fig. 4F). This implies that the regulation of gap junction between cochlear supporting on 
active cochlear amplification have a critical role in the high sound intensity region, too. 
Indeed, it has been reported that supporting cells can reduce cochlear sensitivity as shown in 
intense sound stimulation [21–22].
In previous study, we reported that this Cx26 cKO mice have no significant hair cell 
degeneration and normal endocochlear potential (EP), which is a driving force for K+ ions 
passing through mechanical transduction channels producing auditory receptor currents [17]. 
The cochlea in Cx26 cKO mice also displayed normal development and structure (Fig. 1C) 
[17]. As mentioned above, connexin gap junctions in the cochlea only exist in the cochlear 
supporting cells not in the hair cells [7,9]. Also, there is no direct electrical coupling 
between supporting cells and hair cells [14–16]. So far, the mechanism underlying the effect 
of connexin gap junctions on OHC electromotility and active cochlear amplification still 
remains unclear. In previous study, we reported the effect of gap junctions between cochlear 
supporting cells on OHC electromotility through the direct mechanical coupling [17]. It has 
been reported that connexins have non-channel function to influence cell cytoskeleton 
formation, besides formation of gap junctional channels [23]. Whether Cx26 deficiency can 
reduce cytoskeleton formation in the cochlear supporting cells needs to be further 
investigated in future.
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In the clinic, Cx26 mutations can cause progressive late-onset hearing loss and congenital 
deafness [6,12,13]. Recent studies demonstrated that congenital deafness is associated with 
Cx26 deficiency induced cochlear developmental disorders [20,24–26], whereas late-onset 
hearing loss may resulted from the reduction of active cochlear amplification, even OHCs 
have no connexin expressions [17,18,26]. However, the commonly assumed K+-recycling 
defect is not a primary deafness mechanism for Cx26 deficiency induced hearing loss [26]. 
In this experiment, we found that the effect of gap junction on active cochlear amplification 
and hearing is progressive, extending from basal high-frequency region to apical low-
frequency region with mouse age (Figs. 2–4). The increase in ABR thresholds in Cx26 cKO 
mice was also increased as muse age increased (Fig. 3A&C). These new data further 
indicate that cochlear gap junctions may also play an important role in aging-related hearing 
loss and noise-induced hearing loss.
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* Effect of Cx26 KO on active cochlear amplification is age-dependent
* Hearing and amplification progressively reduce from high to low frequency
* Speed of hearing loss extending in frequency is a logarithmic function with 
age
* Hearing loss and amplification reduction at low and high frequencies are 
different
Zong et al. Page 8






















Deletion of Cx26 in the cochlea in Cx26-Prox1 cKO mice. A–B: Immunofluorescent 
staining for Cx26 (green) and prestin (red) in WT mice with the cochlear cross-section and 
whole-mounting preparation. Outer hair cells (OHCs) are visualized by prestin labeling. A 
white arrow indicates Deiters cell (DC) and outer pillar cell (OPC) area. C–F: 
Immunofluorescent staining of the cochlea for Cx26 and prestin in the Cx26-Prox1 cKO 
mice. A white arrow in panel C indicates no Cx26 labeling in the DC and OPC area. White 
asterisks in panel D–F represent OHC-DC-OPC area in the whole-mounting preparation, in 
which Cx26 labeling is absent while Cx30 labeling remains. Scale bar = 50 µm.
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Progressive increase in ABR thresholds in Cx26-Prox1 cKO mice. A–F: The thresholds of 
ABR at different postnatal days (P15–80) recorded from 6–12 ears in Cx26 cKO mice and 
8–16 ears in WT mice. Cyan color circles indicate the earliest occurrence of significant 
increase in ABR thresholds in different frequencies in Cx26 cKO mice. Hearing loss occurs 
early in high-frequency region and then extends to the low-frequency region. **: P<0.01, 
one-way ANOVA with a Bonferroni correction.
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Progressive hearing loss extending speed and frequency difference of hearing loss in Cx26-
Prox1 cKO mice. A: ABR threshold increase at different frequencies in Cx26 cKO mice. 
Asterisks with different colors represent the earliest occurring time of significant increase in 
ABR thresholds at different frequencies. B: The speed of progressive hearing loss from 
high-frequencies to low-frequencies in Cx26 cKO mice. Earliest occurrence of significant 
increases in ABR thresholds at different frequencies was plotted with mouse age. A solid 
line represents common logarithmic function fitting, showing as linear fitting in the plot with 
a common logarithmic scale in frequency: log y (Frequency, kHz) = 2.087−0.0198 * × 
(postnatal day), r=0.998. C: Progressive increases in ABR thresholds at different frequencies 
in Cx26 cKO mice with mouse age. Asterisks with different colors represent the earliest 
occurring time of significant increase in ABR thresholds at different frequencies. **: 
P<0.01, one-way ANOVA with a Bonferroni correction.
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Progressive reduction of acoustic emission in Cx26-Prox1 cKO mice. DPOAE (2f1–f2) at 
different postnatal days (P15–80) recorded from Cx26 cKO mice (6-24 ears) and WT mice 
(6-30 ears). A–D: Progressive reduction of DPOAE in Cx26-Prox1 cKO mice in different 
frequencies. The reduction first occurs in the high-frequency region and then extends to the 
low-frequency region. Before P25, there is no any reduction in DPOAE in the recording 
frequency regions. However, at P30 afterward, significant reduction in DPOAE can be seen 
in 8-20 kHz (panel B-D). E: Decrease of DPOAE in Cx26 cKO mice (referring to those in 
WT mice) at different frequencies and postnatal days. Different color asterisks represent the 
earliest detection of significant reduction in DPOAE at different frequencies. F: Decrease of 
DPOAE in Cx26 cKO mice at different stimulus sound intensities (I/O plot) and different 
postnatal days. The reduction of DPOAE in Cx26 cKO mice appears large in high-
intensities. One and two asterisks represent P < 0.05 and 0.01 (one-way ANOVA with a 
Bonferroni correction), respectively.
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